Joel Greenblatt acquired 5.71 Thousand Neurocrine Biosciences shares worth $661 Thousand. That's 0.01% of their equity portfolio (966th largest holding). The first Neurocrine Biosciences trade was made in Q1 2012. Since then Joel Greenblatt bought shares thirteen more times and sold shares on fourteen occasions. The investor's estimated purchase price is $729 Thousand, resulting in a loss of 9.4%.